3 research outputs found
An Interactive Leadership Conversation Among the Generations
Succession planning has been a hot topic of discussion for several years. Many conversations are centered around the development of leadership to take the helm of jurisdictions. This session invites Millennials and Gen-Z to the table to tell us exactly what they need
Longitudinal assessment of cystic fibrosis pulmonary diseaseusing clinical, biochemical and emerging microbiological techniques
Cystic Fibrosis (CF) causes chronic lower respiratory tract infection leading to morbidity and mortality. CF Pulmonary Exacerbations (CFPEs) cause accentuated symptoms and increase mortality. The definition and aetiology of CFPEs has however proved elusive. Recently, culture independent techniques have shown that there is much greater diversity of bacteria than previously detected by culture dependent methods. Building on this, in the work presented here, the bacteria in respiratory samples from adults with CF were studied over a 12 month period. Each subject provided thrice weekly sputum samples for analysis by culture and culture independent microbiological methods. Concurrently an in-depth assessment of their subjective and objective health using Visual Analogue Scales (VAS) and spirometry (FEV1) was undertaken. Inflammation markers were also measured.A total of 2061 samples from fourteen adults (mean age 30.2; mean FEV1% predicted 53.3%; 6 females; 8 ?F508 homozygotes) were collected. Subjective VAS measures correlated with objective spirometric measures. However, previously unsuspected complexity of subjective symptomatology was found. Ribosomal clone sequence analysis identified 90 different species, including 15 not previously reported in CF lung disease. Notably 44% of species detected were obligate anaerobes, and 72% were species previously associated with the human oro-pharynx. During the study period, subjects experienced 42 CFPEs requiring treatment. New species were not seen to enter the bacterial community as aetiological agents for CFPEs. However, whilst treatment for CFPEs caused a large fall in the proportion of anaerobic species, no significant change in the proportion of Pseudomonas aeruginosa was detected.Significant and potentially important differences in bacterial community composition, structure and stability between subjects separated by gender, genotype and lung function were observed. Moreover, the presence of certain species correlated with subjects suffering frequent CFPEs.The results presented here give new insights in to the complexity of symptoms and bacterial diversity in CF pulmonary diseas
The characterisation of polymicrobial bacterial communities in the lower respiratory tract of individuals with chronic pulmonary disease
Microbial diversity encompasses the whole of the Earth’s biosphere and is incredibly vast. The microbial diversity of three disparate micro-environments using two culture-independent techniques (denaturing gradient gel electrophoresis (DGGE) and 454-pyrosequencing) were revealed. Five commercially available DNA polymerase (pol) enzymes were assessed in determining the bacterial community generated in sandy soil. The V3 region of the 16S rRNA gene was targeted for amplification by polymerase chain reaction (PCR). Using a PCR-DGGE approach, different DNA pols exhibited differences in the DGGE profiles produced. Both high-fidelity DNA pols Ex Taq™ Hot Start (HS) and Platinum® Pfx detected greater microbial diversity present within sandy soil than the other DNA polymerase enzymes.
We employed Ex Taq™ HS to characterise the microbial communities present in two chronic respiratory tract diseases, non-cystic fibrosis bronchiectasis (nCFBR) and chronic obstructive pulmonary disease (COPD). Seventy individuals expectorated sputum, and using 16S and 28S rRNA PCR-DGGE polymicrobial communities were revealed. From the 70 patients investigated, 20 presented with symptoms consistent with an exacerbation, the remainder being clinically stable. Demographic and culture data were used in constrained ordination analyses to identify any significant associations between these data and changes in the sputum microbiota. The data presented indicates that bacterial lung communities in adult nCFBR patients have distinct differences between exacerbating and clinically stable episodes. Persistent colonisation by Pseudomonas aeruginosa is significantly associated with reduced lung function, and is negatively correlated with Haemophilus influenzae carriage. Bacterial communities seem to be predominantly assembled by stochastic processes. Fungal taxa present were scarce.
Stable COPD populations have been previously investigated using culture-dependent techniques. Eleven clinically stable COPD patients had a bronchoalveolar lavage (BAL) fluid taken from the right lower lobe. Both 16S and 28S rRNA PCR-DGGE was performed on all clinical samples from extracted DNA. Co-migration of bands was then compared to a 16S and 28S standard ladder consisting of pure cultivars. Additionally, execution of 454-pyrosequencing and interrogation of the V3-V5 region of 16S rRNA genes resulted in 1799 unique OTUs being identified. Dominant bacterial genera identified were Streptococcus, Arthrobacter, and Staphylococcus respectively. Bacterial taxa identified were then subjected to multivariate statistical analysis to identify relationships between the microbial communities and patient phenotypes. Metagenomic analysis demonstrated that heterogeneous bacterial populations exist in all eleven individuals. This preliminary study shows that the lungs of COPD sufferers are colonised with multiple species of bacteria and demonstrate that a complex microbial community is present. Furthermore, bacterial phylotypes resolved to class-level indicated three potential drivers of community structure within the COPD lung microbiome: lung function, moderate and severe COPD progression, and smoking status in cohort. The identification of a greater number of bacterial taxa was also apparent in culture-negative patients using both PCR-DGGE and 454-pyrosequencing approaches
